Accumulating data suggest that potent AR inhibition with ENZ can increase glucocorticoids receptor (GR) expression, which regulates about 50% of AR-responsive genes re-expression, thus promoting PCa progression despite the blockage of AR signaling (Narayanan et al., 2016). Here, AR is linked to posterior cortical atrophy.